The Leukemia & Lymphoma Society (LLS) today announced it has committed $40.3 million in new research investments to advance the most promising blood cancer science at leading academic and medical centers around the world, including Dana-Farber Cancer Institute in Boston; Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in New York; MD Anderson Cancer Center in Houston; Fondazione Centro San Raffaele in Milan; and South Australian Health & Medical Research Institute in Adelaide.
This $40.3 million investment, comprised of 75 new research grants in LLS’s portfolio of 300 projects, will fund a diverse array of research to find better treatments and cures for patients with leukemia, lymphoma, myeloma and other blood cancers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554855-lls-invests-millions-new-research-treatment-cures/
Cutanea Life Sciences, Inc. (CLS), an emerging U.S. prescription product development company, formally unveiled its new digital presence, www.cutanea.com, to the dermatology community in conjunction with this winter’s annual gathering of dermatologists from the U.S and around the world. CLS has a stream of innovative product candidates in different stages of development that cover an array of skin conditions, including acne, rosacea, psoriasis and warts caused by human papillomavirus (HPV).
CLS’s new digital presence demonstrates the company’s intent to change the way that customers think about a valued dermatology partner. CLS believes that it can make an impact in the current state of dermatology practice through its commitment to focus on unmet and underserved patient needs. In turn this will help medical professionals optimize their practice time through CLS products and services.
To view the multimedia release go to:
http://www.multivu.com/players/English/7743651-cutanea-life-sciences-dermatology/
Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK), the world's largest leisure travel company with 10 global cruise line brands, today announced it has developed the world’s first interactive guest experience platform capable of transforming vacation travel into a highly personalized and elevated level of customized service for millions of guests.
The company unveiled the Ocean Medallion™, a first-of-its-kind wearable device that enables a personal concierge by bridging the physical and digital worlds to deliver a new level of personalized service not previously considered possible -- including sophisticated wayfinding, food and beverage on demand, an array of interactive gaming, personalized entertainment experiences and more. The quarter-sized, 1.8-ounce disc can be accessorized with jewelry, clips, key chains and bands or simply carried in a pocket or pocketbook.
To view the multimedia release go to:
http://www.multivu.com/players/English/8003551-carnival-corporation-ces-2017/
Volvo Cars, the premium carmaker, has announced a close partnership with Google, one of the world’s largest technology companies, to develop the next generation of its award-winning in-car infotainment and connectivity solution based on Android, offering access to a wide array of apps and services. It will launch on new Volvo models within two years.
The partnership promises to revolutionise how Volvo customers engage and interact with their cars. The large catalogue of popular Android apps – developed by Google, Volvo, or third party app developers – will offer connected and predictive services in and around the car.
“We are making an important strategic step with the Google partnership. Google’s platform and services will enhance the user experience by enabling more personalisation possibilities, while Android will offer increased flexibility from a development perspective,” said Henrik Green, Senior Vice President Research & Development at Volvo Car Group.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8103651-volvo-cars-google-android-connected/
We are at snaptron.com are expert for the manufacturing of the metal domes in every shape and sizes, our main category of domes product are custom dome, standard domes and domes array. These all type of domes information is available on your website.
BloodCenter of Wisconsin’s Diagnostic Laboratories, part of Versiti, today announced the launch of seven hematology genetics test panels. The new test panels enhance and expand BloodCenter’s genetic testing capability to include a vast array of non-malignant hematology disorders, including platelet function disorders, inherited thrombocytopenia and congenital neutropenias, providing one of the most comprehensive test menus in hematology.
BloodCenter’s integration of functional and genetic testing provides a unique approach to diagnosing complex hematology disorders, providing a comprehensive review of each patient for improved patient care and outcomes.
To view the multimedia release go to:
https://www.multivu.com/players/English/8126851-bloodcenter-of-wisconsin-versiti-hematology-genetics-test-panels/
